NCT00602290
Effectiveness of Methylphenidate in Improving Cognition and Function in Older Adults With Depression
See it on ClinicalTrials.gov ↗143 people
54.5%
45.5%
78 womenmiddle line = equal numbers65 men
- Phase
- PHASE4
- Paid for by
- University of California, Los Angeles
- Finished
- 2013-02
- Health conditions
- Depression
- Who could join
- Anyone
- Ages
- 60 Years – no maximum
- Average age
- mean 69.7 years
- Age 65+
- 73.4%
- Weight (BMI)
- Not reported
- Pregnancy recorded
- Not reported
- Menopause recorded
- Not reported
- Results shown by sex
- Not split by sex
- Race
- Not reported
Women left out
- No heart disease
Women with heart disease, heart rhythm problems or a past heart attack were turned away.
“Severe or acute medical illness (e.g., major surgery, metastatic cancer, stroke, heart attack) 6 months prior to study entry”
- No seizures
Women with epilepsy or past seizures were turned away.
“Requires electroconvulsive therapy (ECT) or received ECT within 3 months prior to study entry”
- No mental health conditions
Women with depression, bipolar disorder or other mental health conditions were turned away.
“History of psychiatric illness or a substance abuse disorder other than unipolar depression, diagnosed prior to the onset of the first depressive episode”
- No cancer
Women with current or past cancer were turned away.
“Severe or acute medical illness (e.g., major surgery, metastatic cancer, stroke, heart attack) 6 months prior to study entry”
Study titles and rules are shown in their original English.